Determining clinical biomarkers to predict long-term SARS-CoV-2 antibody response among COVID-19 patients in Bangladesh

BACKGROUND: Information on antibody responses following SARS-CoV-2 infection, including the magnitude and duration of responses, is limited. In this analysis, we aimed to identify clinical biomarkers that can predict long-term antibody responses following natural SARS-CoV-2 infection. METHODOLOGY: I...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Tasnuva, Hasan, S. M. Tafsir, Akter, Afroza, Tauheed, Imam, Akhtar, Marjahan, Rahman, Sadia Isfat Ara, Bhuiyan, Taufiqur Rahman, Ahmed, Tahmeed, Qadri, Firdausi, Chowdhury, Fahima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244648/
https://www.ncbi.nlm.nih.gov/pubmed/37293303
http://dx.doi.org/10.3389/fmed.2023.1111037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244648/
https://www.ncbi.nlm.nih.gov/pubmed/37293303
http://dx.doi.org/10.3389/fmed.2023.1111037

Ejemplares similares